Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
Sponsor: Shanghai Zhongshan Hospital
Summary
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
Official title: A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Acne Vulgaris
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-06
Completion Date
2026-12
Last Updated
2025-06-05
Healthy Volunteers
No
Conditions
Interventions
dihydroartemisinin
DHA 40mg tid for 90 days
Locations (1)
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China